药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Bismuth subsalicylate
Practolol
Regorafenib may increase the bradycardic activities of Practolol.
Bismuth subsalicylate
Bevantolol
Regorafenib may increase the bradycardic activities of Bevantolol.
Bismuth subsalicylate
Ruxolitinib
Ruxolitinib may increase the bradycardic activities of Regorafenib.
Bismuth subsalicylate
Ivabradine
Regorafenib may increase the bradycardic activities of Ivabradine.
Bismuth subsalicylate
Ceritinib
Regorafenib may increase the bradycardic activities of Ceritinib.
Bismuth subsalicylate
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Regorafenib.
Bismuth subsalicylate
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Regorafenib.
Bismuth subsalicylate
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Regorafenib.
Bismuth subsalicylate
Armodafinil
The metabolism of Regorafenib can be increased when combined with Armodafinil.
Bismuth subsalicylate
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Regorafenib.
Bismuth subsalicylate
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Regorafenib.
Bismuth subsalicylate
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Regorafenib.
Pirbuterol
Vibegron
Mirabegron may increase the smooth muscle relaxing activities of Vibegron.
Pirbuterol
Relugolix
The serum concentration of Relugolix can be increased when it is combined with Mirabegron.
Pirbuterol
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Mirabegron.
Pirbuterol
Pralsetinib
The serum concentration of Pralsetinib can be increased when it is combined with Mirabegron.
Pirbuterol
Satralizumab
The serum concentration of Mirabegron can be decreased when it is combined with Satralizumab.
Pirbuterol
Oliceridine
The serum concentration of Oliceridine can be increased when it is combined with Mirabegron.
Pirbuterol
Abametapir
The serum concentration of Mirabegron can be increased when it is combined with Abametapir.
Pirbuterol
Tucatinib
Mirabegron may decrease the excretion rate of Tucatinib which could result in a higher serum level.